Insulet (PODD) director reports 477-share RSU grant on Form 4
Insulet Corp (PODD) disclosed a director equity award on Form 4.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Insulet Corp (PODD) disclosed a director equity award on Form 4. On 10/31/2025, the reporting person received an initial grant tied to 477 shares, reported as an “A” (acquisition) at $0. Following the transaction, the filer beneficially owned 477 shares, held directly.
The award was granted as restricted stock units (RSUs) that fully vest on April 30, 2026, and are settled one-for-one in shares of common stock.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 477 | $0.00 | $0.00 |
Footnotes (1)
- F1. Initial equity award in the form of restricted stock units ("RSUs"). RSUs fully vest on April 30, 2026. The RSUs are settled in shares of common stock on a one-for-one basis.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Insulet (PODD) report on this Form 4?
What type of award was reported by Insulet (PODD)?
When do the reported RSUs for PODD vest?
What was the transaction code and price on the Form 4?
What is the ownership form after the transaction?
AI-generated analysis. How Rhea-AI works. Not financial advice.